Clinical Research
Clinical Trials in Abdominal Transplantation
Clinical trials within the Divison of Abdominal Transplantation include: Tolerance Induction, EVB-induced post-transplant lymphoma, and the following Stanford-based trials for liver, kidney, intestine, pacreas, diabetes, and hepatocellular carcinoma.
This page provides an auto-populated up-to-date list of Stanford Clinical Trials in: liver, kidney, intestine, pancreas, diabetes, hepatocellular carcinoma, and pediatric transplant.
-
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Stanford is currently not accepting patients for this trial. -
The Insulin-Only Bionic Pancreas Bridging Study
Stanford is currently not accepting patients for this trial. -
The Effects of High and Low Blood Glucose Values on the Brain in Children With Type 1 Diabetes Mellitus
Stanford is currently not accepting patients for this trial. -
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Stanford is currently not accepting patients for this trial. -
Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Stanford is currently not accepting patients for this trial. -
TrialNet Pathway to Prevention of T1D
Stanford is currently accepting patients for this trial. -
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension)
Stanford is currently not accepting patients for this trial. -
T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus
Stanford is currently not accepting patients for this trial. -
Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)
Stanford is currently not accepting patients for this trial. -
Supporting Parents of Young Children With Type 1 Diabetes in Closed-Loop System
Stanford is currently not accepting patients for this trial. -
Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients
Stanford is currently not accepting patients for this trial. -
Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery
Stanford is currently not accepting patients for this trial. -
Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease
Stanford is currently not accepting patients for this trial. -
Rituximab in New Onset Type 1 Diabetes
Stanford is currently not accepting patients for this trial. -
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
Stanford is currently not accepting patients for this trial. -
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Stanford is currently not accepting patients for this trial. -
Prescribed Physical Activity in Improving Sleep and Physical Performance in Patients Undergoing Stem Cell Transplant
Stanford is currently not accepting patients for this trial. -
Medtronic Treat to Range (TTR) Closed-Loop Control
Stanford is currently not accepting patients for this trial. -
Rituximab for Pediatric Renal Transplant Rejection
Stanford is currently not accepting patients for this trial. -
On-Line Intervention to Lower Cardiovascular Risk in Pediatric Heart Transplant Patients
Stanford is currently not accepting patients for this trial.